Healthcare Industry News: C.R. Bard
News Release - April 21, 2009
Covidien Files Patent Infringement Lawsuit over Davol's Mesh Fixation Device and Applier
NORTH HAVEN, Conn.--(HSMN NewsFeed)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that it has filed a lawsuit in the United States District Court for the District of Delaware against Davol, Inc., a wholly owned subsidiary of C.R. Bard, relating to its mesh fixation device and applier. The lawsuit contends that Davol’s recently released Sorbafix™ device infringes multiple claims of Covidien’s U.S. Patent Number 6,562,051.The patent generally relates to a system for controllably discharging fasteners from an applicator. Covidien is asking the federal court to enjoin Davol from continuing to make and sell its Sorbafix™ device, as well as for compensatory damages.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.
Source: Covidien
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
